HUP9904201A3 - Transfecting composition usable in gene therapy combining a recombinant virus incorporating an exogenous nucleic acid, a non-viral and non-plasmid transfecting agent - Google Patents

Transfecting composition usable in gene therapy combining a recombinant virus incorporating an exogenous nucleic acid, a non-viral and non-plasmid transfecting agent

Info

Publication number
HUP9904201A3
HUP9904201A3 HU9904201A HUP9904201A HUP9904201A3 HU P9904201 A3 HUP9904201 A3 HU P9904201A3 HU 9904201 A HU9904201 A HU 9904201A HU P9904201 A HUP9904201 A HU P9904201A HU P9904201 A3 HUP9904201 A3 HU P9904201A3
Authority
HU
Hungary
Prior art keywords
transfecting
viral
nucleic acid
gene therapy
recombinant virus
Prior art date
Application number
HU9904201A
Other languages
Hungarian (hu)
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of HUP9904201A1 publication Critical patent/HUP9904201A1/en
Publication of HUP9904201A3 publication Critical patent/HUP9904201A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00—Vectors comprising a targeting moiety
    • C12N2810/10—Vectors comprising a non-peptidic targeting moiety
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00—Vectors comprising a targeting moiety
    • C12N2810/40—Vectors comprising a peptide as targeting moiety, e.g. a synthetic peptide, from undefined source
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00—Vectors comprising a targeting moiety
    • C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00—Vectors comprising a targeting moiety
    • C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
    • C12N2810/80—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates
    • C12N2810/85—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates mammalian
    • C12N2810/859—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates mammalian from immunoglobulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HU9904201A 1996-11-29 1997-11-28 Transfecting composition usable in gene therapy combining a recombinant virus incorporating an exogenous nucleic acid, a non-viral and non-plasmid transfecting agent HUP9904201A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9614693A FR2756491B1 (en) 1996-11-29 1996-11-29 TRANSFECTING COMPOSITION USEFUL IN GENE THERAPY ASSOCIATED WITH A RECOMBINANT VIRUS INCORPORATING EXOG ENE NUCLEIC ACID, A NON-VIRAL AND NON-PLASMIDIC TRANSFECTING AGENT

Publications (2)

Publication Number Publication Date
HUP9904201A1 HUP9904201A1 (en) 2000-04-28
HUP9904201A3 true HUP9904201A3 (en) 2002-01-28

Family

ID=9498192

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9904201A HUP9904201A3 (en) 1996-11-29 1997-11-28 Transfecting composition usable in gene therapy combining a recombinant virus incorporating an exogenous nucleic acid, a non-viral and non-plasmid transfecting agent

Country Status (13)

Country Link
EP (1) EP0948636A1 (en)
JP (1) JP2001514485A (en)
KR (1) KR20000057307A (en)
AU (1) AU737846B2 (en)
BR (1) BR9713434A (en)
CA (1) CA2272637A1 (en)
CZ (1) CZ188299A3 (en)
FR (1) FR2756491B1 (en)
HU (1) HUP9904201A3 (en)
IL (1) IL130053A0 (en)
NO (1) NO992577L (en)
SK (1) SK70999A3 (en)
WO (1) WO1998023765A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100764890B1 (en) * 2005-11-14 2007-10-09 한국화학연구원 Anticancer agent using liposome by polyethylenimine conjugated with DSPE and preparation method
WO2008097623A2 (en) * 2007-02-07 2008-08-14 Gradalis, Inc. Methods and compositions for modulating sialic acid production and treating hereditary inclusion body myopathy
KR100980395B1 (en) 2008-06-27 2010-09-07 재단법인서울대학교산학협력재단 Polymer/DNA complex for non-viral DNA carrier
JP5944622B2 (en) * 2011-04-08 2016-07-05 株式会社ブリヂストン Gene transfer agent composition
EP2821489B1 (en) * 2012-03-02 2017-02-22 Japan Science And Technology Agency Method for constructing functional nucleic acid molecule, and nucleic acid combination to be used in said method

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2646161B1 (en) * 1989-04-17 1991-07-05 Centre Nat Rech Scient NEW LIPOPOLYAMINES, THEIR PREPARATION AND THEIR USE
US5552309A (en) * 1994-09-30 1996-09-03 Indiana University Foundation Use of polyols for improving the introduction of genetic material into cells
FR2727679B1 (en) * 1994-12-05 1997-01-03 Rhone Poulenc Rorer Sa NEW TRANSFECTION AGENTS AND THEIR PHARMACEUTICAL APPLICATIONS
FR2730637B1 (en) * 1995-02-17 1997-03-28 Rhone Poulenc Rorer Sa PHARMACEUTICAL COMPOSITION CONTAINING NUCLEIC ACIDS, AND USES THEREOF
FR2741066B1 (en) * 1995-11-14 1997-12-12 Rhone Poulenc Rorer Sa NEW TRANSFECTION AGENTS AND THEIR PHARMACEUTICAL APPLICATIONS

Also Published As

Publication number Publication date
EP0948636A1 (en) 1999-10-13
FR2756491B1 (en) 1999-01-08
IL130053A0 (en) 2000-02-29
JP2001514485A (en) 2001-09-11
CZ188299A3 (en) 1999-09-15
AU737846B2 (en) 2001-08-30
HUP9904201A1 (en) 2000-04-28
AU7401098A (en) 1998-06-22
SK70999A3 (en) 2000-03-13
KR20000057307A (en) 2000-09-15
BR9713434A (en) 2000-02-01
NO992577L (en) 1999-07-28
NO992577D0 (en) 1999-05-28
FR2756491A1 (en) 1998-06-05
CA2272637A1 (en) 1998-06-04
WO1998023765A1 (en) 1998-06-04

Similar Documents

Publication Publication Date Title
WO2000054813A3 (en) Use of recombinant gene delivery vectors for treating or preventing diseases of the eye
BR9405507A (en) Defective recombinant adenovirus cell line and pharmaceutical composition
ZA958686B (en) Viral vectors and use in gene therapy
ZA949104B (en) Recombinant viruses and their use in gene therapy
AU9692198A (en) Gene delivery compositions and methods
ZA952563B (en) Recombinant viruses their preparation and their use in gene therapy
GB9721909D0 (en) Gene delivery vectors and their uses
IL181695A0 (en) Methods for cultivating cells and propagating viruses
AU1927797A (en) Vectors based on recombinant defective viral genomes, and their use in the formulation of vaccines
AU4089899A (en) Stable envelope proteins for retroviral, viral and liposome vectors and use in gene and drug therapy
HUP9904201A3 (en) Transfecting composition usable in gene therapy combining a recombinant virus incorporating an exogenous nucleic acid, a non-viral and non-plasmid transfecting agent
IL117116A0 (en) A medical composition for the in vivo transfection and expression of exogenes
AU5008296A (en) Recombinant viruses expressing lecithin-cholesterol acyltransferase, and uses thereof in gene therapy
AU9269898A (en) Artificial viruses derived from papillomavirus, and their uses, in particular gene therapy
AU7665396A (en) Recombinant viruses containing mobile genetic elements and methods of use in gene therapy
MX9702078A (en) Adenovirus-derived viral vectors having two therapeutic genes: suicide and immunopotentiating.
IL112993A0 (en) Recombinant niruses, their preparation and their use in gene therapy
IL112992A0 (en) Recombinant viruses, their preparation and their use in gene therapy
PL346859A1 (en) Recombinant celo virus and celo virus dna
ZA971070B (en) Transfectant composition useful in gene therapy asA water control gate. sociating with a recombinant virus incorporating an exogenous nucleic acid and a non-viral and non-plasmid transfection agent.
IL112994A0 (en) Recombinant viruses, their preparation and their use in gene therapy
AU1872599A (en) Genetically-modified myogenic progenitors and their use in cell and gene therapy
ZA952286B (en) Recombinant viruses their preparation and their use in gene therapy
AU2003200630A1 (en) Mammalian genes involved in viral infection and tumor suppression
AU3698699A (en) Vectors and viruses used in gene therapy